Cancer Communications View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2018

PUBLISHER

BioMed Central

LANGUAGE

en

HOMEPAGE

http://cjcjournal.biomedcentral.com

Recent publications latest 20 shown

  • 2019-12 Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center
  • 2019-12 A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia
  • 2019-12 Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
  • 2019-12 Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis
  • 2019-12 Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
  • 2019-12 The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study
  • 2019-12 The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
  • 2019-12 TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis
  • 2019-12 The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
  • 2019-12 Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
  • 2019-12 Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
  • 2019-12 Correction to: Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study
  • 2019-12 Mucinous colorectal adenocarcinoma: clinical pathology and treatment options
  • 2019-12 Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
  • 2019-12 Primary intrathoracic liposarcoma: a clinical analysis of 31 cases
  • 2019-12 Recent trends from the results of clinical trials on gastric cancer surgery
  • 2019-12 Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial
  • 2018-12 Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
  • 2018-12 Tumor vasculature: a sally port for inhibiting cancer cell spreading
  • 2018-12 Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B11001", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cancer Research", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.399", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.516", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.822", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "4.111", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.814", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.155", 
            "type": "Rating"
          }
        ], 
        "description": "

    As a prestigious, international journal in the field of oncology, Cancer Communications publishes basic, clinical, and translational cancer research. It enjoys a large readership and is widely respected as the official journal of the Chinese Anti-Cancer Association and the US Chinese Anti-Cancer Association. With an average-time-to-first-decision after submission of just 25 days, the journal enables authors to comply with funder requirements on open access, and also waives the publication costs for selected, high quality articles. Cancer Communications is edited by an expert Editorial Board and a team of dedicated scientific editors.

    ", "editor": [ { "familyName": "Xu", "givenName": "Rui-Hua", "type": "Person" } ], "id": "sg:journal.1041144", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "1000-467X", "2523-3548" ], "license": "Fully Open Access", "name": "Cancer Communications", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "41144" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40880" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2018243080" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "1000-467X/CHINESE JOURNAL OF CANCER" ] }, { "name": "scopus_id", "type": "PropertyValue", "value": [ "28691" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101723675", "101498232" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "44491" ] } ], "publisher": { "name": "BioMed Central", "type": "Organization" }, "publisherImprint": "BioMed Central", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1041144" ], "sdDataset": "journals", "sdDatePublished": "2021-01-20T04:59", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "2018", "type": "Periodical", "url": "http://cjcjournal.biomedcentral.com" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1041144'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1041144'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1041144'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1041144'


     

    This table displays all metadata directly associated to this object as RDF triples.

    105 TRIPLES      21 PREDICATES      35 URIs      29 LITERALS      16 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1041144 schema:about sg:ontologies/product-market-codes/B11001
    2 sg:ontologies/product-market-codes/H33160
    3 schema:contentRating N27bd2a3facd34f4590e8d26daa4e87d5
    4 N51f762e0cbae47238c01f3e95bd39dc5
    5 Naad33e5fb3824fe79da79e125b842a24
    6 Nd4e86127045e429e9b560261d0c9a191
    7 Nd754673120a44a3ab2e50db40daa444a
    8 Nf17796c32db049e3878e1f550d821aa2
    9 schema:description <p>As a prestigious, international journal in the field of oncology, <i>Cancer Communications</i> publishes basic, clinical, and translational cancer research. It enjoys a large readership and is widely respected as the official journal of the Chinese Anti-Cancer Association and the US Chinese Anti-Cancer Association. With an average-time-to-first-decision after submission of just 25 days, the journal enables authors to comply with funder requirements on open access, and also waives the publication costs for selected, high quality articles. <i>Cancer Communications</i> is edited by an expert Editorial Board and a team of dedicated scientific editors.</p>
    10 schema:editor N11db1e48226a4c0a8e47e09060de0842
    11 schema:inLanguage en
    12 schema:isAccessibleForFree true
    13 schema:issn 1000-467X
    14 2523-3548
    15 schema:license Fully Open Access
    16 schema:name Cancer Communications
    17 schema:productId N0e7e743af6354025b87a41df06f17bcf
    18 N11522faefcac4b9d9dff944fc3a94e8a
    19 N2f6f571f9a814adf96e964d3a46e76f1
    20 N52a864dac5c54d0e916a331f29e77aa4
    21 N671902dd37114b10af5457530900ca44
    22 N6ee83c01fa1844a9a414360f5a1d7ae1
    23 N7b00475acd3848e9b3afbc291bf21ebe
    24 schema:publisher Ne6079a8cbecb40c79907f03dadca287d
    25 schema:publisherImprint BioMed Central
    26 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1041144
    27 schema:sdDatePublished 2021-01-20T04:59
    28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    29 schema:sdPublisher N840549bbf65c465cbb0b013b2dfe0bd4
    30 schema:startYear 2018
    31 schema:url http://cjcjournal.biomedcentral.com
    32 sgo:license sg:explorer/license/
    33 sgo:sdDataset journals
    34 rdf:type schema:Periodical
    35 N0e7e743af6354025b87a41df06f17bcf schema:name scopus_id
    36 schema:value 28691
    37 rdf:type schema:PropertyValue
    38 N11522faefcac4b9d9dff944fc3a94e8a schema:name lccn_id
    39 schema:value 2018243080
    40 rdf:type schema:PropertyValue
    41 N11db1e48226a4c0a8e47e09060de0842 rdf:first Nea9ba1c0f9d34544b8096e2622762427
    42 rdf:rest rdf:nil
    43 N257f0028b3624c6eaccf875a7226a13c rdf:first sjr
    44 rdf:rest rdf:nil
    45 N27bd2a3facd34f4590e8d26daa4e87d5 schema:author N257f0028b3624c6eaccf875a7226a13c
    46 schema:ratingValue 1.516
    47 rdf:type schema:Rating
    48 N2efca92bd13b4a1dbe21a91948301cba rdf:first impact_factor_wos
    49 rdf:rest rdf:nil
    50 N2f6f571f9a814adf96e964d3a46e76f1 schema:name era_ids_id
    51 schema:value 44491
    52 rdf:type schema:PropertyValue
    53 N51f762e0cbae47238c01f3e95bd39dc5 schema:author Ne17e7ec296f542c1a5837f1c603fb3f0
    54 schema:dateCreated 2015
    55 schema:ratingValue 2.814
    56 rdf:type schema:Rating
    57 N52a864dac5c54d0e916a331f29e77aa4 schema:name dimensions_id
    58 schema:value 41144
    59 rdf:type schema:PropertyValue
    60 N671902dd37114b10af5457530900ca44 schema:name springer_id
    61 schema:value 40880
    62 rdf:type schema:PropertyValue
    63 N6ee83c01fa1844a9a414360f5a1d7ae1 schema:name wos_id
    64 schema:value 1000-467X/CHINESE JOURNAL OF CANCER
    65 rdf:type schema:PropertyValue
    66 N76a3b7411f15437b973abcf7b678ff08 rdf:first impact_factor_wos
    67 rdf:rest rdf:nil
    68 N7b00475acd3848e9b3afbc291bf21ebe schema:name nlm_unique_id
    69 schema:value 101498232
    70 101723675
    71 rdf:type schema:PropertyValue
    72 N840549bbf65c465cbb0b013b2dfe0bd4 schema:name Springer Nature - SN SciGraph project
    73 rdf:type schema:Organization
    74 Naad33e5fb3824fe79da79e125b842a24 schema:author N2efca92bd13b4a1dbe21a91948301cba
    75 schema:dateCreated 2014
    76 schema:ratingValue 2.155
    77 rdf:type schema:Rating
    78 Nb08493d971dd40b2841ca3c4c1cec265 rdf:first impact_factor_wos
    79 rdf:rest rdf:nil
    80 Nd1e02867ac354763bb0031f24d9ac4b1 rdf:first snip
    81 rdf:rest rdf:nil
    82 Nd4e86127045e429e9b560261d0c9a191 schema:author Nb08493d971dd40b2841ca3c4c1cec265
    83 schema:dateCreated 2017
    84 schema:ratingValue 3.822
    85 rdf:type schema:Rating
    86 Nd754673120a44a3ab2e50db40daa444a schema:author Nd1e02867ac354763bb0031f24d9ac4b1
    87 schema:ratingValue 1.399
    88 rdf:type schema:Rating
    89 Ne17e7ec296f542c1a5837f1c603fb3f0 rdf:first impact_factor_wos
    90 rdf:rest rdf:nil
    91 Ne6079a8cbecb40c79907f03dadca287d schema:name BioMed Central
    92 rdf:type schema:Organization
    93 Nea9ba1c0f9d34544b8096e2622762427 schema:familyName Xu
    94 schema:givenName Rui-Hua
    95 rdf:type schema:Person
    96 Nf17796c32db049e3878e1f550d821aa2 schema:author N76a3b7411f15437b973abcf7b678ff08
    97 schema:dateCreated 2016
    98 schema:ratingValue 4.111
    99 rdf:type schema:Rating
    100 sg:ontologies/product-market-codes/B11001 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    101 schema:name Cancer Research
    102 rdf:type schema:DefinedTerm
    103 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    104 schema:name Oncology
    105 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...